GRASS (Grass MATA MPL Real-world Assessment Study)
Germany1,000 participantsStarted 2026-03-11
Plain-language summary
Objective of this non-interventional study (NIS) is to collect data on the use of Grassmuno® in routine clinical practice.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
At the physician's discretion and based on the current Summary of Product Characteristics (SmPC), study participation may be offered to patients who
* are male and female patients
* are 18 years of age or older
* treated in accordance with the SmPC of Grassmuno® for IgE-mediated moderate to severe allergic rhinitis and/or rhinoconjunctivitis (without asthma or with well-controlled asthma) triggered by grass pollen.
* Patients will only be enrolled in the study after the treatment decision has been made
Exclusion Criteria:
At the physician's discretion, the study should not be offered to the following patients:
* Patients who are not sufficiently proficient in or do not adequately understand the German language, as this would prevent adequate comprehension of study-relevant documents.
* In addition, patients should not be included if any of the contraindications listed in the current Summary of Product Characteristics (SmPC) are present.